SENSENIG BETHANY (Chief Financial Officer) received a stock award from 9 METERS BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/29/2023ACC: 0001578563-23-000009
Officer· Chief Financial Officer
Since Jan 2022
+50.18K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
50.18K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50.18K
Price / share
—
Trade value
—
% of position
New position
3/27/2023
0.00→50.18K
Total
Net shares
+50.18K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/27/2023 | A · Award | +50.18K | — | — | New position | 0.00 | 50.18K |
| Total | +50.18K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported